arrow
E

Elisa Agostinetto

institut jules bordet and l'universite libre de bruxelles
H指数:25
被引数:2,635

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chemotherapy Type and Survival in Young BRCA1/2 Carriers With HER2-Negative Early Breast Cancer

BRCA1/2携带者中HER2阴性早期乳腺癌年轻患者的化疗类型与生存期

2026-07-140
OA
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2− breast cancer: a randomized phase 2 trial

durvalumab和oleclumab新辅助立体定向放射治疗ER HER2 − 乳腺癌: 一项随机2期试验

2026-06-250
OAAI
Body Mass Index in Postmenopausal Women with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: An Exploratory Analysis of the LORELEI trial.

雌激素受体阳性、HER2阴性早期乳腺癌绝经后女性中的体重指数:LORELEI试验的探索性分析

2026-06-120
PRE
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer

癌症患者对mRNA抗SARS-CoV-2疫苗接种的长期免疫反应

2026-05-200
OAAI
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal

HER2阳性乳腺癌患者的中枢神经系统及软脑膜转移:综合综述和治疗算法提案

2026-05-170
PRE
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study

BRCA1/2携带者早期乳腺癌患者的放射治疗管理:一项国际队列研究

2026-04-040
OAAI
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trial

根据雌激素受体和HER2表达,评估辅助治疗中帕妥珠单抗和曲妥珠单抗的获益:APHINITY试验的亚组分析

2026-04-030
PRE
Association Between Alcohol Consumption and Breast Cancer Incidence and Prognosis: A Systematic Review and Meta-Analysis

酒精摄入与乳腺癌发病率及预后的关系:一项系统评价和Meta分析

2026-02-050
OAAI
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

新型治疗策略及乳腺癌合并中枢神经系统(CNS)转移患者的关键研究重点

2025-12-200
OAAI
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study

个性化循环肿瘤DNA检测和基因组分析在NeoRHEA研究中

2025-12-050
OAAI
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study

Palbociclib和内分泌疗法减弱早期乳腺癌的适应性抗肿瘤免疫:NeoRHEA 2期研究

2025-11-260
OAAI
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY

年轻乳腺癌患者BRCA1/2致病性或可能致病性变异的类型和位置与表型和预后之间的关系: 一项国际队列研究的结果

2025-11-170
OAAI
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer

RSC4All 作为一种机器学习列线图,用于预测 HR+/HER2- 淋巴结阴性早期乳腺癌的 RSClin™ 结果

2025-10-070
OAAI
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

年轻BRCA携带者在孕期被诊断患有乳腺癌后,再次怀孕的安全性

2025-08-130
OAAI
Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives

脑成像筛查在转移性乳腺癌中的应用:患者和医师的视角

2025-08-120
OAAI
Breastfeeding after breast cancer in young BRCA carriers

Blondeaux, E.; Delucchi, V.; Mariamidze, E.; Bernstein-Molho, R.; Frank, S.; Ferrari, A.; Linn, S.; Jeong Kim, H.; Agostinetto, E.; Paluch-Shimon, S.; 等. 乳腺癌后母乳喂养在年轻BRCA携带者中的应用. J. Natl. Cancer Inst. 2025, djaf177. [Google Scholar] [CrossRef] [PubMed]

2025-08-012
OAAI